Home › NDC Lookup › RxCUI directory › RxCUI 349253

Bosentan 62.5 MG Oral Tablet — RxCUI 349253

RxNorm drug concept · Semantic clinical drug
RxCUI 349253 Semantic clinical drug · SCD ● Current RxNorm concept 11 FDA products 31 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI349253
Official nameBosentan 62.5 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asbosentan (as bosentan hydrochloride) 62.5 MG Oral Tablet
FDA products mapped11
Package NDCs mapped31
Reported Medicaid activity (SDUD)814 prescriptions · 12 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Bosentan: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Pulmonary arterial hypertension, or PAH, means the blood pressure inside the arteries in your lungs is dangerously high. That forces your heart to work much harder than it should....
  • What exactly is bosentan treating — what's wrong with my lungs?
  • Please don't skip them — this is one of the most important parts of being on bosentan. The drug can raise liver enzyme levels, which is a sign of stress on your liver, and this can...
  • Why do I need a blood test every single month? Can I skip one if I feel fine?
📖 Read our full Bosentan guide →

🕸️ Concept Web — How Bosentan 62.5 MG Oral Tablet Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Bosentan 62.5 MG Oral Tablet RxCUI 349253

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Bosentan 75207
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Tracleer 323502
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Bosentan Oral Tablet 378980
    • Bosentan Oral Product 1163076
    • Bosentan Pill 1163077
    • Bosentan Oral Tablet [Tracleer] 367715
    • Tracleer Oral Product 1178626
    • Tracleer Pill 1178627
    • Oral Tablet 317541
    • Oral Product 1151131
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Bosentan 62.5 MG SCDC · 351036
  • Bosentan Oral Tablet SCDF · 378980
  • Bosentan Oral Product SCDG · 1163076
  • Bosentan Pill SCDG · 1163077

Brand-Name Concepts

  • Bosentan 62.5 MG Oral Tablet [Tracleer] SBD · 352066
  • Bosentan 62.5 MG [Tracleer] SBDC · 575815
  • Bosentan Oral Tablet [Tracleer] SBDF · 367715
  • Tracleer Oral Product SBDG · 1178626
  • Tracleer Pill SBDG · 1178627
  • Tracleer BN · 323502

📦 FDA Products & Package NDCs

11 products · 31 package NDCs
31 package NDCs map to RxCUI 349253 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00591-2511-60 60 TABLET, FILM COATED in 1 BOTTLE (0591-2511-60) bosentan Actavis Pharma, Inc. 2019-06-19
00591-2512-60 60 TABLET, FILM COATED in 1 BOTTLE (0591-2512-60) bosentan Actavis Pharma, Inc. 2019-06-19
47335-0038-64 10 BLISTER PACK in 1 CARTON (47335-038-64) / 3 TABLET, FILM... Bosentan Sun Pharmaceutical Industries, Inc. 2019-04-26
47335-0038-86 60 TABLET, FILM COATED in 1 BOTTLE (47335-038-86) Bosentan Sun Pharmaceutical Industries, Inc. 2019-04-26
47335-0039-64 10 BLISTER PACK in 1 CARTON (47335-039-64) / 3 TABLET, FILM... Bosentan Sun Pharmaceutical Industries, Inc. 2019-04-26
47335-0039-86 60 TABLET, FILM COATED in 1 BOTTLE (47335-039-86) Bosentan Sun Pharmaceutical Industries, Inc. 2019-04-26
66215-0101-03 10 BLISTER PACK in 1 CARTON (66215-101-03) / 3 TABLET, FILM... Tracleer Actelion Pharmaceuticals US, Inc. 2012-10-02
66215-0101-06 1 BOTTLE, PLASTIC in 1 CARTON (66215-101-06) / 60 TABLET, F... Tracleer Actelion Pharmaceuticals US, Inc. 2001-11-20
66215-0102-03 10 BLISTER PACK in 1 CARTON (66215-102-03) / 3 TABLET, FILM... Tracleer Actelion Pharmaceuticals US, Inc. 2012-10-02
66215-0102-06 1 BOTTLE, PLASTIC in 1 CARTON (66215-102-06) / 60 TABLET, F... Tracleer Actelion Pharmaceuticals US, Inc. 2001-11-20
66215-0232-56 4 BLISTER PACK in 1 CARTON (66215-232-56) / 14 TABLET, FOR... Tracleer Actelion Pharmaceuticals US, Inc. 2021-07-29
68382-0446-01 100 TABLET, COATED in 1 BOTTLE (68382-446-01) Bosentan Zydus Pharmaceuticals USA Inc. 2019-05-01
68382-0446-05 500 TABLET, COATED in 1 BOTTLE (68382-446-05) Bosentan Zydus Pharmaceuticals USA Inc. 2019-05-01
68382-0446-14 60 TABLET, COATED in 1 BOTTLE (68382-446-14) Bosentan Zydus Pharmaceuticals USA Inc. 2019-05-01
68382-0446-28 180 TABLET, COATED in 1 BOTTLE (68382-446-28) Bosentan Zydus Pharmaceuticals USA Inc. 2019-05-01
68382-0446-77 10 BLISTER PACK in 1 CARTON (68382-446-77) / 10 TABLET, COA... Bosentan Zydus Pharmaceuticals USA Inc. 2019-05-01
68382-0447-01 100 TABLET, COATED in 1 BOTTLE (68382-447-01) Bosentan Zydus Pharmaceuticals USA Inc. 2019-05-01
68382-0447-05 500 TABLET, COATED in 1 BOTTLE (68382-447-05) Bosentan Zydus Pharmaceuticals USA Inc. 2019-05-01
68382-0447-14 60 TABLET, COATED in 1 BOTTLE (68382-447-14) Bosentan Zydus Pharmaceuticals USA Inc. 2019-05-01
68382-0447-28 180 TABLET, COATED in 1 BOTTLE (68382-447-28) Bosentan Zydus Pharmaceuticals USA Inc. 2019-05-01
68382-0447-77 10 BLISTER PACK in 1 CARTON (68382-447-77) / 10 TABLET, COA... Bosentan Zydus Pharmaceuticals USA Inc. 2019-05-01
70771-1017-01 100 TABLET in 1 BOTTLE (70771-1017-1) Bosentan Zydus Lifesciences Limited 2019-05-01
70771-1017-04 10 BLISTER PACK in 1 CARTON (70771-1017-4) / 10 TABLET in 1... Bosentan Zydus Lifesciences Limited 2019-05-01
70771-1017-05 500 TABLET in 1 BOTTLE (70771-1017-5) Bosentan Zydus Lifesciences Limited 2019-05-01
70771-1017-06 60 TABLET in 1 BOTTLE (70771-1017-6) Bosentan Zydus Lifesciences Limited 2019-05-01
70771-1017-08 180 TABLET in 1 BOTTLE (70771-1017-8) Bosentan Zydus Lifesciences Limited 2019-05-01
70771-1018-01 100 TABLET in 1 BOTTLE (70771-1018-1) Bosentan Zydus Lifesciences Limited 2019-05-01
70771-1018-04 10 BLISTER PACK in 1 CARTON (70771-1018-4) / 10 TABLET in 1... Bosentan Zydus Lifesciences Limited 2019-05-01
70771-1018-05 500 TABLET in 1 BOTTLE (70771-1018-5) Bosentan Zydus Lifesciences Limited 2019-05-01
70771-1018-06 60 TABLET in 1 BOTTLE (70771-1018-6) Bosentan Zydus Lifesciences Limited 2019-05-01
70771-1018-08 180 TABLET in 1 BOTTLE (70771-1018-8) Bosentan Zydus Lifesciences Limited 2019-05-01
Observed labelers: Zydus Lifesciences Limited (10) · Zydus Pharmaceuticals USA Inc. (10) · Actelion Pharmaceuticals US, Inc. (5) · Sun Pharmaceutical Industries, Inc. (4) · Actavis Pharma, Inc. (2) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.